117 related articles for article (PubMed ID: 2168192)
1. Prognosis at presentation of small cell carcinoma of the lung.
Allan SG; Stewart ME; Love S; Cornbleet MA; Smyth JF; Leonard RC
Eur J Cancer; 1990; 26(6):703-5. PubMed ID: 2168192
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and prognostic staging system for small cell lung cancer.
Kawahara M; Fukuoka M; Saijo N; Nishiwaki Y; Ikegami H; Tamura T; Shimoyama M; Suemasu K; Furuse K
Jpn J Clin Oncol; 1997 Jun; 27(3):158-65. PubMed ID: 9255270
[TBL] [Abstract][Full Text] [Related]
3. Small-cell carcinoma of the lung: derivation of a prognostic staging system.
Sagman U; Maki E; Evans WK; Warr D; Shepherd FA; Sculier JP; Haddad R; Payne D; Pringle JF; Yeoh JL
J Clin Oncol; 1991 Sep; 9(9):1639-49. PubMed ID: 1651996
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation.
Osterlind K; Andersen PK
Cancer Res; 1986 Aug; 46(8):4189-94. PubMed ID: 3015384
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors in unresectable lung cancer].
Urata A
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2035-42. PubMed ID: 2840034
[TBL] [Abstract][Full Text] [Related]
6. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
Albain KS; Crowley JJ; LeBlanc M; Livingston RB
J Clin Oncol; 1990 Sep; 8(9):1563-74. PubMed ID: 2167954
[TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer.
Michael M; Babic B; Khokha R; Tsao M; Ho J; Pintilie M; Leco K; Chamberlain D; Shepherd FA
J Clin Oncol; 1999 Jun; 17(6):1802-8. PubMed ID: 10561218
[TBL] [Abstract][Full Text] [Related]
8. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition.
Sculier JP; Chansky K; Crowley JJ; Van Meerbeeck J; Goldstraw P;
J Thorac Oncol; 2008 May; 3(5):457-66. PubMed ID: 18448996
[TBL] [Abstract][Full Text] [Related]
9. The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up.
Bremnes RM; Sundstrom S; Aasebø U; Kaasa S; Hatlevoll R; Aamdal S;
Lung Cancer; 2003 Mar; 39(3):303-13. PubMed ID: 12609569
[TBL] [Abstract][Full Text] [Related]
10. [Pre-therapeutic prognostic factors of survival in small cell bronchial cancer. Retrospective study in a series of 112 patients].
Quoix E; Hedelin G; Seibert R; Popin E; Dietemann A; Roeslin N; Pauli G
Rev Mal Respir; 1993; 10(1):29-34. PubMed ID: 8383869
[TBL] [Abstract][Full Text] [Related]
11. Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer - a retrospective single institution analysis.
Hermes A; Gatzemeier U; Waschki B; Reck M
Respir Med; 2010 Dec; 104(12):1937-42. PubMed ID: 20719490
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow involvement in small cell lung cancer. Clinical significance and correlation with routine laboratory variables.
Tritz DB; Doll DC; Ringenberg QS; Anderson S; Madsen R; Perry MC; Yarbro JW
Cancer; 1989 Feb; 63(4):763-6. PubMed ID: 2536586
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging.
Vincent MD; Ashley SE; Smith IE
Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1589-99. PubMed ID: 2828070
[TBL] [Abstract][Full Text] [Related]
14. Advanced Lung Cancer Inflammation Index, a New Prognostic Score, Predicts Outcome in Patients With Small-Cell Lung Cancer.
He X; Zhou T; Yang Y; Hong S; Zhan J; Hu Z; Fang W; Qin T; Ma Y; Zhao Y; Cheng Z; Huang Y; Zhao H; Yang G; Zhang L
Clin Lung Cancer; 2015 Nov; 16(6):e165-71. PubMed ID: 25922292
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment serum lactate dehydrogenase as additional staging parameter in patients with small-cell lung carcinoma.
Stokkel MP; van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
J Cancer Res Clin Oncol; 1998; 124(3-4):215-9. PubMed ID: 9619749
[TBL] [Abstract][Full Text] [Related]
16. The impact of abdominal computerized tomography on the pretreatment staging and prognosis of small cell lung cancer.
Hirsch FR; Osterlind K; Jensen LI; Thomsen C; Peters K; Jensen F; Hansen HH
Ann Oncol; 1992 Jun; 3(6):469-74. PubMed ID: 1323323
[TBL] [Abstract][Full Text] [Related]
17. An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research.
Rawson NS; Peto J
Br J Cancer; 1990 Apr; 61(4):597-604. PubMed ID: 2158808
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
[TBL] [Abstract][Full Text] [Related]
19. The relative value of conventional staging procedures for developing prognostic models in extensive-stage small-cell lung cancer.
Sheehan RG; Balaban EP; Cox JV; Frenkel EP
J Clin Oncol; 1990 Dec; 8(12):2047-53. PubMed ID: 2172474
[TBL] [Abstract][Full Text] [Related]
20. Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.
Jørgensen LG; Osterlind K; Genollá J; Gomm SA; Hernández JR; Johnson PW; Løber J; Splinter TA; Szturmowicz M
Br J Cancer; 1996 Aug; 74(3):463-7. PubMed ID: 8695366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
